Charles River Laboratories International, Inc. (CRL) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-76.6%

$80.71

vs $344.63 price

Levered DCF

$58.41

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

2.99

Grey zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-69.99×	930.8×	25.5×	22.77×	48.49×	33.99×	29.55×	23.98×
P/B	3.19×	2.76×	3.37×	3.72×	7.48×	5.85×	4.55×	4.12×
P/S	2.51×	2.36×	2.93×	2.78×	5.35×	4.23×	2.84×	2.39×
EV / EBITDA	31.51×	20.81×	14.44×	14.13×	26.71×	18.62×	16.39×	13.66×
Gross margin	30.5%	32.9%	36.4%	36.8%	37.7%	36.7%	36.6%	37.1%
Operating margin	12.6%	5.6%	14.9%	16.4%	16.7%	14.8%	13.4%	14.6%
Net margin	-3.6%	0.3%	11.5%	12.2%	11.0%	12.5%	9.6%	10.0%
Current ratio	1.29×	1.41×	1.52×	1.32×	1.23×	1.43×	1.44×	1.61×
Debt / equity	0.97×	0.79×	0.85×	1.04×	1.26×	1.02×	1.24×	1.29×
Interest coverage	4.74×	1.8×	4.52×	10.98×	7.98×	5.01×	5.77×	5.2×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-4.6%	0.3%	13.2%	16.3%	15.4%	17.2%	15.4%	17.2%
Return on invested capital	8.4%	0.9%	7.1%	7.9%	8.1%	7.5%	7.3%	8.0%
Return on assets	-2.0%	0.1%	5.8%	6.4%	5.6%	6.6%	5.4%	5.9%
Free cash flow yield	5.1%	5.2%	3.0%	2.7%	2.8%	3.1%	4.6%	5.5%
Earnings yield	-1.4%	0.1%	3.9%	4.4%	2.1%	2.9%	3.4%	4.2%
Enterprise value	$12.9B	$12.1B	$14.9B	$13.9B	$21.9B	$14.3B	$9.2B	$6.9B
Net debt / EBITDA	6.94×	4.35×	2.7×	2.9×	3.61×	2.51×	3.17×	2.96×
Cash conversion cycle (days)	84	84	98	76	67	90	82	92